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SummAry
Sarcoidosis is an inflammatory multisystem disorder of unknown cause. Approximately 5-7% of patients manifest symptoms of central 
nervous system involvement, or neurosarcoidosis. Cranial neuropathy usually entails facial nerve palsy and optic neuritis. Sudden hear-
ing loss has been reported in fewer than 20 cases. herewith, two new cases of sudden hearing loss due to probable neurosarcoidosis are 
reported, each having a quite different clinical course. in one case, unilateral sudden hearing loss and facial palsy were the presenting 
symptoms of systemic sarcoidosis, while in the second, unilateral sudden deafness occurred despite ongoing immunosuppressive treatment 
for systemic sarcoidosis.
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riASSunTo
La sarcoidosi è una malattia infiammatoria idiopatica multisistemica. Le manifestazioni cliniche di un interessamento del sistema nervoso 
centrale – neurosarcoidosi – si rilevano in circa il 5-7% dei pazienti. Il nervo facciale e il nervo ottico sono i nervi cranici più comunemente 
affetti. L’ipoacusia improvvisa è stata riportata in meno di 20 casi. Il presente lavoro riporta due nuovi casi di ipoacusia improvvisa dovuta 
a probabile neurosarcoidosi dal decorso clinico differente. L’ipoacusia improvvisa e la paralisi del nervo facciale monolaterale sono stati i 
primi segni di una sarcoidosi sistemica nel primo caso, mentre nel secondo l’ipoacusia improvvisa monolaterale si è verificata nonostante 
il trattamento immunosoppressivo in corso.
pArole ChiAve: Ipoacusia improvvisa • Sarcoidosi • Neurosarcoidosi • Potenziali evocati uditivi del tronco encefalico • Risonanza 
magnetica nucleare
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Introduction
Sarcoidosis is an inflammatory multi-system disorder of 
unknown  cause. Approximately  5-7%  of  patients  with 
systemic sarcoidosis manifest symptoms of central nerv-
ous system (CnS) involvement, so-called neurosarcoido-
sis (nS) 1 2, while imaging studies can detect neurological 
disease in 10% of all patients with sarcoidosis 3. however, 
prospective  studies  reveal  subclinical  neurological  in-
volvement of the CnS evidence in up to 26% of patients 
affected by sarcoidosis 4. The most prevalent symptom of 
nS in up to 80% of cases, is a cranial neuropathy, with 
the facial and optic nerve being most affected 1 2 5. eighth 
nerve involvement is found in 1-7% of neurosarcoidosis 
patients 1 2 5-7. The histopathological correlation of audio-
vestibular  dysfunction  in  neurosarcoidosis  was  report-
ed by Babin et al.  8, in 1984, in autopsy findings from 
a deaf patient with nS. The Authors found generalized 
cranial nerve neuropathy with perivascular lymphocytic 
and granulomatous inflammation which were particularly 
striking in acoustic, vestibular and facial nerves within the 
internal auditory meatus. These processes were associated 
with diffuse cochlear destruction with the organ of Corti 
almost completely degenerated. Because of the extent and 
degree of cochlear destruction without significant infil-
tration or inflammation within the cochleae, the Authors 
concluded that audiovestibular impairment in nS is likely 
due to vascular occlusion and ischemia 8.
hearing loss, in approximately 90% of reported cases, is 
characterised by sudden or rapidly progressive onset and e. Cama et al.
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in more than 90% of patients, vestibular symptoms with 
abnormal vestibular functioning tests have been reported. 
in almost 50% of the cases at least partial hearing recov-
ery has been achieved after high-dose systemic steroid 
administration,  while  balance  disorders  recover  either 
spontaneously or after treatment 8.
oral corticosteroids are the cornerstone of treatment of 
nS, although relapse or deterioration have been reported, 
after a good initial response, upon dose reduction 5-7.
despite the fact that cranial neuropathy affects up to 80% 
of patients with nS, detailed descriptions of sudden hear-
ing loss, possibly accompanying symptoms and course 
have been reported in fewer than 20 cases 9-13. herewith, 
two new cases of sudden hearing loss showing a quite dif-
ferent clinical evolution are reported.
Case 1
A 29-year-old male from Senegal was hospitalized at the 
ear,  nose,  and Throat  (enT)  Clinic  of Treviso  general 
hospital, in december 2004, with left facial nerve paraly-
sis and sudden left hearing loss. he was otherwise healthy. 
pure-tone audiometry was performed upon admission and 
revealed  profound  sensorineural  hearing  loss,  in  the  left 
ear, and mild, in the right (Fig. 1a). The patient was treated 
with systemic prednisone (1 mg/kg per day for 10 days) 
and pentoxifylline (400 mg oS t.i.d. for 3 weeks). A slight 
hearing improvement was recorded two weeks later in both 
ears (Fig. 1b). however, after corticosteroid suspension in 
January 2005, the patient was referred to the Audiology and 
phoniatrics Service because of sudden right hearing loss. 
A further pure-tone audiometry was performed revealing 
only residual hearing (125-1000 hz) in the right ear and se-
vere hearing loss in the left (Fig. 1c). distortion products 
otoacoustic emissions (dpoAes) were absent bilaterally. 
Auditory brainstem response (ABr) was absent in the 
right ear. despite severe hearing impairment in the left 
ear, wave v was identified with absolute latency 5.87 ms, 
but showing poor morphology and repeatability (Fig. 2a). 
Two months later ABr was grossly abnormal in both ears 
(Fig. 2b).
Contrast-enhanced  magnetic  resonance  imaging  (mri) 
was normal. due to conjunctival hyperaemia, the patient 
underwent ophthalmologic evaluation that revealed right 
anterior uveitis.
routine chest X-ray showed multiple small pulmonary 
cavities (< 1 cm) within the apical segment of the left 
pulmonary  lobe.  Tuberculosis  was  excluded  by  means 
of  negative  mantoux  cutaneous  reaction  and  absence 
of Koch bacilli in the broncho-alveolar lavage culture. 
Analysis of fluid and cells of broncho-alveolar lavage re-
vealed an increased Cd4/Cd8 lymphocyte ratio (31) and 
alveolar macrophages. multiple trans-bronchial biopsies 
from the superior pulmonary lobe showed non-specific 
inflammatory  infiltration.  Serum  angiotensin  convert-
ing enzyme (ACe), at 98 u/l, exceeded normal values 
(nv: 8-52 u/l).
liver enzymes, alanine amino-transferase (AlT), aspar-
tate  amino-transferase  (AST)  and  glutamyl-transpepti-
dase (ggT) levels were increased. Abdominal computed 
tomography (CT) revealed multiple lymphadenopathy at 
the hepatic hilus, and cholelithiasis. percutaneous hepatic 
biopsy showed non-caseating and giant-cell granulomas 
leading, one month after the first symptoms, to the diag-
nosis of systemic sarcoidosis with pulmonary, hepatic, oc-
ular and possible CnS involvement. Systemic high dose 
prednisone treatment was administered for 6 months and 
then tapered to a maintenance dosage of 7.5 mg/day.
despite treatment, the patient’s hearing evolved to pro-
found deafness within 2 months. hearing aids were pre-
scribed with very little benefit, while cochlear implant 
application was refused by the patient. Two years later, 
he showed no clinical signs of a relapse of systemic sar-
coidosis.
Fig.  1a-c.  Pure  tone  audiometry  performed  at  admission,  December 
2004 (a), after 10 days of treatment with Prednisone 1 mg/kg/day, Janu-
ary 2005 (b), and a few days after suspension of prednisone and pentoxyfil-
line (c). (BC = AC: Bone Conduction = Air Conduction. x: left air conduction 
threshold; o: right air conduction threshold).
Fig. 2a-b. (a) Auditory Brainstem Response (ABR) performed in January 
2005, a few days after suspension of prednisone; the corresponding hearing 
threshold is reported in Fig. 1c. (b) ABR recordings performed two months 
later showing highly desynchronized response.
a b cSudden hearing loss in sarcoidosis
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Case 2
A 44-year-old male from Sri lanka was referred to the Au-
diology and phoniatrics Service, in April 2009, for ABr re-
cording for sudden right hearing loss. A detailed case histo-
ry was collected. The patient reported that onset of sudden 
right hearing loss, was preceded by diplopia and unsteadi-
ness over the previous weeks. he had suffered, since 1996, 
from diabetes mellitus type ii and systemic sarcoidosis that 
was diagnosed in 2007. Since then he had been receiving 
prednisone (7.5 mg/day), hydroxychloroquine, alendronic 
acid, colecalcipherol and ursodesoxycholic acid and insulin 
substituting previous oral antidiabetics. no other systemic 
diseases were reported. pure tone audiometry revealed nor-
mal hearing in the left ear and mild sensorineural hearing 
loss in the right (Fig. 3a). Acoustic reflexes were obtained 
bilaterally  for  ipsi-lateral  and  contra-lateral  stimulation. 
ABr showed normal morphology and latencies, suggest-
ing  that  the  hearing  impairment  was  of  cochlear  origin 
(Fig. 3b). gadolinium-enhanced cerebral mri was normal. 
Serum ACe levels were within the normal range. Because 
of the negativity of cerebral mri, the absence of unequivo-
cal signs suggesting a relapse of sarcoidosis, the complex 
therapeutic regime and diabetes mellitus, the corticosteroid 
dosage was not modified.
The patient was referred again to our Service 6 months later, 
in november 2009, because of sudden right hearing loss, 
hypoesthesia  of  the  right  auricle  and  frontal  headaches. 
The patient denied changes in hearing acuity in the left ear. 
physical examination did not reveal either facial palsy or 
other cranial nerve involvement. pure tone audiometry re-
vealed right anacusis and mild hearing loss in the left ear 
(Fig. 3c). no ABr was detected on the right side (Fig. 3d). 
Although left ABr showed preserved morphology, abso-
lute latency delay of principal waves and prolonged inter-
peak intervals i-iii (2.66 msec) and i-v (4.65 msec) were 
observed (Fig. 3d). Bi-thermal vestibular testing (Fitzger-
ald-hallpike test) revealed right vestibular hypo-reflexia. 
dpoAes were present in the left ear only. prednisone 
dose was then increased to 37.5 mg/day with complete 
recovery of right auricle hypoaesthesia, but no change in 
the hearing threshold was measurable. Serum ACe levels 
were within the normal range.
The patient was examined one month later because of sud-
den left hearing loss. pure tone audiometry confirmed the 
right anacusis and showed a moderate hearing loss in the 
left ear. dpoAes in the left ear were still present. ABr 
parameters were similar to previous findings. prednisone 
dose was increased to 70 mg/day with some hearing im-
provement within a few days. lumbar puncture showed 
increased  proteins  in  the  cerebrospinal  fluid  (CSF) 
(142 g/l; upper normal limit 45 g/l). CSF glucose levels 
were within the limits, as were lymphocytes.
The patient underwent a new gadolinium enhanced cer-
ebral mri. Axial contrast-enhanced T1-weighted images 
demonstrated  bilateral  enhancement  along  the  internal 
auditory meatus (iAm, Fig. 4a). no other lesions were 
detectable. mri was repeated 2 months later showing fur-
ther, widespread evolution of CnS lesions. post-contrast 
T1-weighted  images  revealed  diffuse  enhancement  of 
basal leptomeningeal, along the myelinic sheath of both 
optical nerves, of trigeminal nerves, and along the pial 
surfaces of the cerebellar folia (Fig. 4b). T2-weighted im-
ages revealed reduced signal intensity within the lateral 
and posterior semicircular canals (lSC and pSC) and the 
cochlea on the right. Absence of endolabyrinthic fluids on 
the right was demonstrated by T2-cis weighted/T2-volu-
metric sequences (Fig. 4c). The patient was scheduled for 
close follow-up, and his hearing has remained stable over 
8 months.
Discussion
Although cranial nerve neuropathy, especially affecting fa-
cial and optic nerves, is a common finding in up to 80% 
of neuro-sarcoidosis patients, eighth nerve involvement is 
seldom reported 1 2 5. To date, 18 case reports of Shl in sar-
Fig. 3a-d. Pure tone audiometry (a) and (b) first ABR performed April 
2009; pure tone audiometry (c) showing right anacusis and mild left hearing 
loss mainly affecting high frequencies and ABR (d), both performed Novem-
ber 2009. NB. Absence of response in right ear and preserved morphology in 
left with prolonged inter-peak intervals mostly due to I-III interval (2.66 msec; 
nv < 2.4 msec) suggesting retro-cochlear involvement. (BC = AC: Bone Con-
duction = Air Conduction. x; left air conduction threshold).
Fig. 4. Gadolinium enhanced cerebral MRI. a) December 2009; Axial con-
trast-enhanced T1-weighted images showing enhancement along internal 
auditory meatus (IAM) bilaterally (a, white arrows); b and c: February 2010; 
b) Post-contrast T1-weighted images revealing diffuse enhancement of 
basal leptomeningeal, of trigeminal nerves (b, white arrows) and along the 
pial surfaces of the cerebellar folia (b, black arrows); c) T2-weighted imag-
es showing reduced signal intensity within the lateral and posterior semi-
circular canals (LSC and PSC) and cochlea on the right (c, white arrows).e. Cama et al.
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coidosis have been described in the english literature 9-13.
According to Zajicek criteria, the neurological symptoms 
experienced by our patients, both affected by systemic sar-
coidosis, are consistent with a diagnosis of probable neu-
rosarcoidosis 7. in Case 1, unilateral facial palsy and Shl, 
the two together were the first clinical manifestations of 
sarcoidosis. Absence of symptoms of systemic sarcoidosis 
and normal mri led to a significant delay in diagnosis and 
the first ten-days’ treatment with prednisone, was clearly 
insufficient to prevent hearing deterioration.
As far as concerns Case 2, the patient had already had sys-
temic sarcoidosis diagnosed and was under immunosup-
pressive therapy when sudden mild hearing loss occurred 
in the right ear. normal ABrs suggested a cochlear site of 
the lesion, that evolved to right sudden anacusis, vestibu-
lar hyporeflexia and absence of ABrs within 6 months. 
Subclinical progression of neurological involvement, al-
though not accompanied by symptoms, was suspected in 
the presence of abnormal prolongation of inter-peak inter-
vals of ABrs that appeared in the left ear. ABr abnormal-
ities even in asymptomatic patients have been reported in 
a few cases 6 14. if found, they should alert the clinician 
to the possibility of evolution of the neurosarcoidosis, in 
order that a close follow-up can be planned and steroid 
treatment started as early as possible to avoid granuloma 
and ensuing scar formation in the neural tissue 6. once 
sudden  left  hearing  loss  occurred,  prednisone  dosage 
was  promptly  increased  obtaining  only  partial  hearing 
improvement. Changes in ABrs preceding sudden hear-
ing loss, could be explained histologically by perineural 
perivascular lymphocytic and granulomatous inflamma-
tion at the junction of the eighth nerve with the brain as 
described in autopsy reports 8.
regarding cerebral gadolinium enhanced mri, this was 
normal in Case 1, whereas in Case 2 only repetition and 
follow-up studies confirmed evolution of CnS lesions. 
lack of abnormality on cerebral mri despite symptoms 
of CnS involvement may be due to extra-cranial involve-
ment of cranial nerves, to initially minimal perineural in-
flammatory infiltration or to the presence of granulomas 
too small to be detected by current imaging techniques 15.
in conclusion, neurosarcoidosis should be kept in mind 
in  differential  diagnosis  of  Shl.  often  accompanying 
symptoms  develop  and  the  diagnosis  requires  several 
days  before  being  established,  but,  if  confirmed,  high 
dose corticosteroids should be started as soon as possible 
to prevent cochlear and neural destruction, thus profound 
hearing loss. once profound deafness occurs, cochlear 
implant is probably not an option for restoring hearing in 
these patients.
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